Evonik Shares Surge Over 8% on Report of BASF Merger Approach

Shares in German specialty chemicals group Evonik Industries (EVKn) surged on Friday following a report that chemicals giant BASF SE has made a formal merger proposal. The news, first reported by the Financial Times, ignited takeover speculation across European markets and sent the stock sharply higher.

The Reported Merger Proposal

According to the Financial Times, BASF approached both Evonik and its primary shareholder, the RAG-Stiftung foundation, with a formal offer. The report, which cited unnamed sources, noted that BASF has been consulting with investment banks on a potential deal structure since earlier in the year, though it cautioned that the preliminary discussions may not result in a definitive agreement.

A combined entity would create a European industrial heavyweight with joint annual revenues of approximately €74 billion. Evonik currently has an enterprise value of roughly €12 billion, including net debt, making it a significant acquisition target for BASF.

Strategic Rationale and Context

The strategic logic for a potential merger is rooted in building scale to better compete with global overcapacity and state-backed producers in China. For BASF, the world's largest chemical company by revenue, the move would align with a broader strategy to streamline operations and pivot its portfolio toward higher-margin businesses.

Ad

The reported approach comes as Evonik navigates a challenging period, having recently faced job cuts and restructuring amid sector-wide weakness. The takeover speculation provided a stark reversal in the stock's fortunes.

Market Reaction

In response to the news, Evonik's shares jumped 8.1% to trade at €19.54 on Friday. The stock reached a new 52-week high of €20.06 intraday, a dramatic turnaround from its recent 52-week low of €12.49.

The stock's performance decisively outpaced the broader German market. The MDAX, Evonik's benchmark index, advanced only modestly, highlighting the specific impact of the M&A news on the company's valuation.